Cagrilintide

Cagrilintide 10mg is a peptide researched for its potential in appetite suppression and weight management.

Cagrilintide

What is Cagrilintide?

Cagrilintide is a synthetic peptide and an amylin receptor agonist, researched for its role in weight management and appetite suppression. It is often studied in combination with other weight loss peptides to enhance fat loss and improve metabolic health.

How It Works (Mechanism of Action)

Cagrilintide mimics the effects of amylin, a hormone that regulates appetite and glucose metabolism. It activates amylin receptors in the brain, reducing hunger and slowing gastric emptying, which leads to increased satiety and reduced food intake.

Potential Benefits & Use Cases

• Weight Loss: Suppresses appetite, aiding in weight reduction.
• Metabolic Health: Improves insulin sensitivity and glucose control.
• Obesity Research: Used in studies for managing obesity and related conditions.

Typical Dosage & Administration

Administration: Subcutaneous injection.

Dosage:

• Typical doses range from 0.5 mg to 2.4 mg per week.
• Often administered once weekly, with gradual dose escalation.

Possible Side Effects

• Nausea: Common during initial use, typically subsides over time.
• Injection Site Reactions: Mild redness or irritation.
• Fatigue: Temporary tiredness in some users.

Other Relevant Details

• Often combined with GLP-1 agonists like Semaglutide for synergistic effects.
• Under investigation for long-term efficacy in obesity treatment.